In a bid to revolutionize drug development, Salesforce’s research project, ProGen, aimed to leverage generative AI to design proteins efficiently. Despite promising results published in a January 2023 Nature Biotech article, the project remained largely dormant until one of its researchers, Ali Madani, founded Profluent, a startup dedicated to commercializing protein-generating technology for pharmaceutical companies. … Continue reading Profluent is transforming drug development with AI-designed proteins